ArticleLeukemia2014

Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.

S Koschmieder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.